Copyright © 2013 Rohini Mehta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Obesity is associated with chronic low-grade inflammation perpetuated by visceral adipose. Other organs, particularly stomach and intestine, may also overproduce proinflammatory molecules. We examined the gene expression patterns in gastric tissue of morbidly obese patients with nonalcoholic fatty liver disease (NAFLD) and compared the changes in gene expression in different histological forms of NAFLD. Stomach tissue samples from 20 morbidly obese NAFLD patients who were undergoing sleeve gas...
Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the devel...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Wester...
The liver is a major target of injury in obese patients. Non-alcoholic fatty liver disease (NAFLD) i...
Approaches to manage nonalcoholic fatty liver disease (NAFLD) are limited by an incomplete understan...
BACKGROUND: Obesity modulates inflammation and activation of immune pathways which can lead to liver...
Obesity modulates inflammation and activation of immune pathways which can lead to liver complicatio...
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common cause of chronic liver ...
OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is an obesity-associated disease, and in obesi...
PMC6719754Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder due to increased accumula...
Background and aims: Pro-inflammatory molecules produced by adipose tissue have been implicated in t...
The prevalence of non-alcoholic fatty liver disease has increased with the obesity pandemic. We anal...
Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the devel...
7 p.Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a world-wide public health problem....
Population studies have linked insulin resistance to systemic low-grade chronic inflammation and hav...
Background: Non-alcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liv...
Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the devel...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Wester...
The liver is a major target of injury in obese patients. Non-alcoholic fatty liver disease (NAFLD) i...
Approaches to manage nonalcoholic fatty liver disease (NAFLD) are limited by an incomplete understan...
BACKGROUND: Obesity modulates inflammation and activation of immune pathways which can lead to liver...
Obesity modulates inflammation and activation of immune pathways which can lead to liver complicatio...
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common cause of chronic liver ...
OBJECTIVES: Non-alcoholic fatty liver disease (NAFLD) is an obesity-associated disease, and in obesi...
PMC6719754Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder due to increased accumula...
Background and aims: Pro-inflammatory molecules produced by adipose tissue have been implicated in t...
The prevalence of non-alcoholic fatty liver disease has increased with the obesity pandemic. We anal...
Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the devel...
7 p.Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming a world-wide public health problem....
Population studies have linked insulin resistance to systemic low-grade chronic inflammation and hav...
Background: Non-alcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liv...
Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the devel...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Wester...
The liver is a major target of injury in obese patients. Non-alcoholic fatty liver disease (NAFLD) i...